In Other News

• Pfizer/BioNTech COVID-19 Vaccine Becomes First to Receive Emergency Validation from WHO

• Rapid COVID-19 Breath Test Could Evaluate Efficacy of Coronavirus Vaccines

• New Machine Learning Algorithm Could Assist Pulmonary Doctors in Optimizing Ventilator Treatment for COVID-19

• Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial

• Three New COVID-19 Vaccines Expected in Early 2021 Could Help Reach Herd Immunity More Quickly

• New, Unique COVID-19 Antibody Test Gives More Detailed Information on How Immune System Reacts To SARS-CoV-2

• Eurofins Genomics Launches Optimized, Cost-Effective, SARS-CoV-2, Next-Generation Sequencing Service

• Sysmex and Kobe University Conduct Clinical Evaluation of New ELISPOT Method to Test for COVID-19 Using Blood

• Oral Drug That Can Restore Lung Function in COVID-19 Could Complement Coronavirus Vaccine

• New Long-Acting Antibody Combination Treatment Could Give COVID-19 Immunity

• New Evidence of Protective Immunity After COVID-19 Infection Gives Hope for Long-Lasting Vaccine Efficacy

• Quidel Receives FDA EUA for Moderately Complex Solana SARS Molecular Test for COVID-19 Diagnosis

• Serious COVID-19 Patients Requiring Brain Imaging Face Higher Risk of Death, Finds Study

• Eurofins Launches COVID-19 PCR Tests with At-Home Self-Sampling Options in Europe

• Twist Bioscience Launches Synthetic RNA Control for UK Variant Strain of SARS-CoV-2

• New Blood-Test Device That Monitors Blood Chemistry Continually Could Be Used to Spot SARS-CoV-2

• Biomarker Detection Platform Configured with MRI System Can Rapidly Screen 100,000 Samples per Day for SARS-CoV-2

• PCR Test Could Detect Genetic Mutations for New Coronavirus Strain

• Pfizer-BioNTech COVID-19 Vaccine Being Tested for Protection Against Coronavirus Mutation and Asymptomatic Transmission

• Randox Unveils SARS-CoV-2 Antibody Test to Determine Previous COVID-19 Infection in Just 1.5 Hours

• New COVID-19 Immunity Study Finds Majority of Coronavirus-Infected People Retain Antibodies for Over Six Months

• RSNA Officially Publishes First Dataset of Annotated COVID-19 Images

• Quidel Receives FDA Emergency Use Authorization for QuickVue SARS Rapid Antigen Test for COVID-19 Diagnosis